Artal Group S.A. Royalty Pharma PLC Transaction History

Artal Group S.A.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$36.12 - $50.05 $9.03 Million - $12.5 Million	-250,000 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$38.56 - $48.36 $19.3 Million - $24.2 Million	-500,000 Reduced 66.67%	250,000 $10.5 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $33.4 Million - $39.1 Million	750,000 New	750,000 $36.4 Million

414

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $10.7B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.